1NY9
Antibiotic binding domain of a TipA-class multidrug resistance transcriptional regulator
Summary for 1NY9
Entry DOI | 10.2210/pdb1ny9/pdb |
Related | 1EXI 1EXJ 1JBG |
NMR Information | BMRB: 5706 |
Descriptor | Transcriptional activator tipA-S (1 entity in total) |
Functional Keywords | all alpha, globin like, transcription |
Biological source | Streptomyces lividans |
Total number of polymer chains | 1 |
Total formula weight | 16452.91 |
Authors | Kahmann, J.D.,Sass, H.J.,Allan, M.G.,Seto, H.,Thompson, C.J.,Grzesiek, S. (deposition date: 2003-02-12, release date: 2003-04-15, Last modification date: 2024-05-22) |
Primary citation | Kahmann, J.D.,Sass, H.J.,Allan, M.G.,Seto, H.,Thompson, C.J.,Grzesiek, S. Structural basis for antibiotic recognition by the TipA-class of multidrug-resistance transcriptional regulators Embo J., 22:1824-1834, 2003 Cited by PubMed Abstract: The TipAL protein, a bacterial transcriptional regulator of the MerR family, is activated by numerous cyclic thiopeptide antibiotics. Its C-terminal drug-binding domain, TipAS, defines a subfamily of broadly distributed bacterial proteins including Mta, a central regulator of multidrug resistance in Bacillus subtilis. The structure of apo TipAS, solved by solution NMR [Brookhaven Protein Data Bank entry 1NY9], is composed of a globin-like alpha-helical fold with a deep surface cleft and an unfolded N-terminal region. Antibiotics bind within the cleft at a position that is close to the corresponding heme pocket in myo- and hemoglobin, and induce folding of the N-terminus. Thus the classical globin fold is well adapted not only for accommodating its canonical cofactors, heme and other tetrapyrroles, but also for the recognition of a variety of antibiotics where ligand binding leads to transcriptional activation and drug resistance. PubMed: 12682015DOI: 10.1093/emboj/cdg181 PDB entries with the same primary citation |
Experimental method | SOLUTION NMR |
Structure validation
Download full validation report